The potential impact of a prophylactic herpes simplex vaccine

Author： Rupp Richard   Bernstein David I  

Publisher： Informa Healthcare

ISSN： 1472-8214

Source： Expert Opinion on Emerging Drugs, Vol.13, Iss.1, 2008-03, pp. : 41-52

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prophylactic Vaccine Strategies and the Potential of Therapeutic Vaccines Against Herpes Simplex Virus

By  

Current Pharmaceutical Design, Vol. 13, Iss. 19, 2007-07 ,pp. : 1975-1988

Bentham Science Publishers

Access to resources Recommend Favorite

Herpes simplex vaccine prevents lesion recurrence

By  

Inpharma, Vol. 1, Iss. 1368, 2002-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Engineered herpes simplex virus vectors for antitumor therapy and vaccine delivery

By Gaston David C   Whitley Richard J   Parker Jacqueline N  

Future Virology, Vol. 6, Iss. 3, 2011-03 ,pp. : 321-340

Future Medicine

Access to resources Recommend Favorite

A herpes simplex vaccine based upon Ligand Epitope Antigen Presentation System

By  

Inpharma, Vol. 1, Iss. 1331, 2002-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Fusogenic Oncolytic Herpes Simplex Viruses as a Potent and Personalized Cancer Vaccine

By  

Current Pharmaceutical Biotechnology, Vol. 13, Iss. 9, 2012-07 ,pp. : 1773-1785

Bentham Science Publishers

Access to resources Recommend Favorite